Skip to content
Pretest - Tumor Board Tuesday - October 26, 2021 (ID: i788-21)
*
1.
Please list your first name, last name, and email:
(Required.)
First name:
Last name:
Email:
*
2.
What is your specialty?
(Required.)
*
3.
How many patients with non-metastatic gastric cancer do you treat each week?
(Required.)
1 to 10
11 to 25
26 to 50
I am not directly involved in patient care
*
4.
According to NCCN guidelines which of the following procedures or tests should be considered for a clinical T3 non-metastatic gastric cancer fit for surgery?
(Required.)
HER2 and PD-L1 testing
Diagnostic laparoscopy
ctDNA
*
5.
Among larger perioperative and/or adjuvant gastroesophageal cancer trials how frequently is dMMR/MSI-H observed?
(Required.)
1-4%
5-9%
>10%